Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 GLOBAL GLUTATHIONE MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. L-GLUTATHIONE

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. ACETYL-GLUTATHIONE

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 GLOBAL GLUTATHIONE MARKET, APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. PHARMACEUTICALS

5.2.1. Market size and forecast

5.3. COSMETICS

5.3.1. Market size and forecast

5.4. FOOD

5.4.1. Market size and forecast

5.5. OTHERS

5.5.1. Market size and forecast

Chapter: 6 GLOBAL GLUTATHIONE MARKET, BY GEOGRAPHY

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. By Type
6.2.3.2. By Application

6.2.4. U.S.

6.2.4.1. Market size and forecast, by Type
6.2.4.2. Market size and forecast, by Application

6.2.5. Canada

6.2.5.1. Market size and forecast, by Type
6.2.5.2. Market size and forecast, by Application

6.2.6. Mexico

6.2.6.1. Market size and forecast, by Type
6.2.6.2. Market size and forecast, by Application

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. By Type
6.3.3.2. By Application

6.3.4. Germany

6.3.4.1. Market size and forecast, by Type
6.3.4.2. Market size and forecast, by Application

6.3.5. France

6.3.5.1. Market size and forecast, by Type
6.3.5.2. Market size and forecast, by Application

6.3.6. UK

6.3.6.1. Market size and forecast, by Type
6.3.6.2. Market size and forecast, by Application

6.3.7. Italy

6.3.7.1. Market size and forecast, by Type
6.3.7.2. Market size and forecast, by Application

6.3.8. Rest of Europe

6.3.8.1. Market size and forecast, by Type
6.3.8.2. Market size and forecast, by Application

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. By Type
6.4.3.2. By Application

6.4.4. China

6.4.4.1. Market size and forecast, by Type
6.4.4.2. Market size and forecast, by Application

6.4.5. Japan

6.4.5.1. Market size and forecast, by Type
6.4.5.2. Market size and forecast, by Application

6.4.6. India

6.4.6.1. Market size and forecast, by Type
6.4.6.2. Market size and forecast, by Application

6.4.7. Australia

6.4.7.1. Market size and forecast, by Type
6.4.7.2. Market size and forecast, by Application

6.4.8. Korea

6.4.8.1. Market size and forecast, by Type
6.4.8.2. Market size and forecast, by Application

6.4.9. Rest of Asia-Pacific

6.4.9.1. Market size and forecast, by Type
6.4.9.2. Market size and forecast, by Application

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. By Type
6.5.3.2. By Application

6.5.4. Brazil

6.5.4.1. Market size and forecast, by Type
6.5.4.2. Market size and forecast, by Application

6.5.5. Saudi Arabia

6.5.5.1. Market size and forecast, by Type
6.5.5.2. Market size and forecast, by Application

6.5.6. South Africa

6.5.6.1. Market size and forecast, by Type
6.5.6.2. Market size and forecast, by Application

6.5.7. Rest of LAMEA

6.5.7.1. Market size and forecast, by Type
6.5.7.2. Market size and forecast, by Application

Chapter: 7 COMPANY PROFILES

7.1. KYOWA HAKKO BIO CO., LTD.

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. SHANDONG JINCHENG BIOLOGICAL PHARMACEUTICAL CO., LTD.

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. KOHJIN LIFE SCIENCES CO., LTD.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. SHENZHEN GSH BIO-TECH CO., LTD.

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. KAIPING GENUINE BIOCHEMICAL PHARMACEUTICAL CO., LTD.

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. NISSOR PHARMACEUTICALS LTD.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments